Literature DB >> 21923163

Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection.

Meng Zheng1, Yinan Zhong, Fenghua Meng, Rui Peng, Zhiyuan Zhong.   

Abstract

The clinical success of gene therapy intimately relies on the development of safe and efficient gene carrier systems. We found here that 1.8 kDa polyethylenimine (PEI) following hydrophobic modification with lipoic acid (LA) mediated nontoxic and highly potent in vitro gene transfection in both HeLa and 293T cells. 1.8 kDa PEI-LA conjugates were prepared with controlled degree of substitution (DS) by coupling LA to PEI using carbodiimide chemistry. Gel electrophoresis measurements showed that the DNA binding ability of 1.8 kDa PEI was impaired by lipoylation, in which an N/P ratio of 2/1 and 4-6/1 was required for 1.8 kDa PEI and 1.8 kDa PEI-LA conjugates, respectively, to completely inhibit DNA migration. Interestingly, dynamic light scattering measurements (DLS) revealed that PEI-LA conjugates condensed DNA into much smaller sizes (183-84 nm) than unmodified 1.8 kDa PEI (444-139 nm) at N/P ratios ranging from 20/1 to 60/1. These polyplexes revealed similar surface charges of ca. +22 to +30 mV. 1.8 kDa PEI-LA(2) polyplexes formed at an N/P ratio of 10/1 were stable against exchange with 12-fold excess of negatively charged dextran sodium sulfate (DSS) relative to DNA phosphate groups while 1.8 kDa PEI controls dissociated at 6-fold excess of DSS, indicating that lipoylation of 1.8 kDa PEI resulted in stronger binding with DNA. Importantly, DNA was released from 1.8 kDa PEI-LA(2) polyplexes upon addition of 10 mM dithiothreitol (DTT). Reduction-triggered unpacking of 1.8 kDa PEI-LA(2) polyplexes was also confirmed by DLS. MTT assays demonstrated that all PEI-LA conjugates and polyplexes were essentially nontoxic to HeLa and 293T cells up to a tested concentration of 50 μg/mL and an N/P ratio of 80/1, respectively. The in vitro gene transfection studies in HeLa and 293T cells showed that lipoylation of 1.8 kDa PEI markedly boosted its transfection activity. For example, 1.8 kDa PEI-LA(2) polyplexes displayed 400-fold and 500-fold higher levels of gene expression than unmodified 1.8 kDa PEI controls, which were ca. 2-fold and 3-fold higher than 25 kDa PEI controls, in serum-free and 10% serum media, respectively. The transfection efficiency decreased with increasing DS, following an order of 1.8 kDa PEI-LA(2) > 1.8 kDa PEI-LA(4) > 1.8 kDa PEI-LA(6) ≫ 1.8 kDa PEI. Confocal laser scanning microscopy (CLSM) studies corroborated that 1.8 kDa PEI-LA(2) delivered and released DNA into the nuclei of HeLa cells more efficiently than 25 kDa PEI. These nontoxic 1.8 kDa PEI-LA conjugates form a superb basis for the development of targeting, biocompatible and highly efficient carriers of gene delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923163     DOI: 10.1021/mp2003797

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

Review 1.  Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.

Authors:  Bruna Corradetti; Simone Pisano; Robert Steven Conlan; Mauro Ferrari
Journal:  J Pharmacol Exp Ther       Date:  2019-02-08       Impact factor: 4.030

Review 2.  Micelle-like nanoparticles as carriers for DNA and siRNA.

Authors:  Gemma Navarro; Jiayi Pan; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2015-01-12       Impact factor: 4.939

3.  In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate.

Authors:  Jianping Wang; Fanfei Meng; Bieong-Kil Kim; Xue Ke; Yoon Yeo
Journal:  Biomaterials       Date:  2019-06-21       Impact factor: 12.479

4.  Enhanced gene transfection efficiency by low-dose 25 kDa polyethylenimine by the assistance of 1.8 kDa polyethylenimine.

Authors:  Hui Zhang; Zhiyi Chen; Meng Du; Yue Li; Yuhao Chen
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

5.  Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.

Authors:  Zhen Xing; Sai Gao; Yan Duan; Haobo Han; Li Li; Yan Yang; Quanshun Li
Journal:  Int J Nanomedicine       Date:  2015-09-09

6.  Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Combined with Modified TAT Peptide to Enhance BMP-2 Production.

Authors:  Yufu Wang; Changcheng You; Rongzhi Wei; Jianing Zu; Chengchao Song; Jing Li; Jinglong Yan
Journal:  Biomed Res Int       Date:  2017-08-17       Impact factor: 3.411

7.  Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma.

Authors:  Mingzhuo Cao; Yong Gao; Mengling Zhan; Nasha Qiu; Ying Piao; Zhuxian Zhou; Youqing Shen
Journal:  Int J Mol Sci       Date:  2019-10-12       Impact factor: 5.923

8.  Improved gene delivery to K-562 leukemia cells by lipoic acid modified block copolymer micelles.

Authors:  Friederike Richter; Prosper Mapfumo; Liam Martin; Jana I Solomun; Franziska Hausig; Jochen J Frietsch; Thomas Ernst; Stephanie Hoeppener; Johannes C Brendel; Anja Traeger
Journal:  J Nanobiotechnology       Date:  2021-03-06       Impact factor: 10.435

Review 9.  Recent advances of biomaterials in biotherapy.

Authors:  Ling Li; Zhi-Yao He; Xia-Wei Wei; Yu-Quan Wei
Journal:  Regen Biomater       Date:  2016-03-05

10.  ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy.

Authors:  Zhanwei Zhou; Qingyan Zhang; Minghua Zhang; Huipeng Li; Gang Chen; Chenggen Qian; David Oupicky; Minjie Sun
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.